Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Biotech
BioVie cuts 'most de-risked program,' will seek partner
BioVie is seeking partners for its “most de-risked program,” a phase 3-ready investigational infusion for patients with refractory ascites.
Gabrielle Masson
Mar 11, 2024 11:12am
Gain's clinical Parkinson's drug restores motor function in mice
Feb 6, 2024 8:00am
FDA approves Abbott’s smallest, longest-lasting DBS implant
Jan 25, 2024 11:57am
Annovis blames ‘data cleaning’ for ph. 3 Parkinson’s data delays
Jan 24, 2024 8:59am
Open science contest uses AI to ID hits for Parkinson’s
Jan 18, 2024 5:00am
FDA approves Medtronic’s rechargeable deep brain stimulator
Jan 10, 2024 10:20am